[1] 国家心血管病中心.中国心血管病报告2016[J].北京:中国大百科
全书出版社,2017.
[2] Wang WZ, Wang D, Liu HM, et al. Trend of declining
stroke mortality in China: reasons and analysis [J]. Stroke
& Vascular Neurology, 2017:e000098.
[3] McAlister FA, Wilkins K, Joffres M, et al. Changes in
the rates of awareness, treatment and control of hypertension
in Canada over the past two decades [J]. CMAJ, 2011
(183):1007-1013.
[4] 国家卫生计生委疾病预防控制局.中国居民营养与慢性病状况报告(2015) [J].北京:人民卫生出版社,2015(11):33-50
[5] He J, Gu D, Reynolds K, et al. Serum total and lipoprotein
cholesterol levels and awareness, treatment, and control
of hypercholesterolemia in China [J]. Circulation, 2004,
110(4):405.
[6] Yang W, Xiao J, Yang Z, et al. Serum lipids and lipoproteins
in Chinese men and women [J]. Circulation, 2012,125
(18):2212.
[7] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常
防治指南(2016 年修订版) [J]. 中华心血管病杂志,2016,44
(10):833-853.
[8] Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic
Pattern of Diabetes and Prediabetes in China in 2013 [J].
JAMA, 2017,317(24):2515-2523.
[9] Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to
control risk factors for cardiovascular disease in type 2 diabetes
patients [J]. American Journal of Medicine, 2013,126
(10):925.